We are live on ! Find out more
IIP

Intermede Investment Partners Portfolio holdings

AUM $2.16B
1-Year Est. Return 18.47%
This Fund
S&P 500
This Quarter Est. Return
+10.59%
1 Year Est. Return
+18.47%
3 Year Est. Return
+69.55%
5 Year Est. Return
+72.34%
10 Year Est. Return
+364.13%
AUM
$957M
AUM Growth
+$104M
Cap. Flow
+$22.4M
Cap. Flow %
2.34%
Top 10 Hldgs %
51.66%
Holding
29
New
2
Increased
18
Reduced
5
Closed
4

Top Buys

Rank Stock Value
1
COL
Rockwell Collins
COL
+$34.4M
2
SPGI icon
S&P Global
SPGI
+$20.2M
3
BIIB icon
Biogen
BIIB
+$13.2M
4
MDT icon
Medtronic
MDT
+$10.4M
5
TSM icon
TSMC
TSM
+$8.11M

Sector Composition

Rank Sector Weight
1 Healthcare 21.74%
2 Communication Services 18.58%
3 Financials 18.23%
4 Technology 13.95%
5 Consumer Discretionary 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCSA icon
1
Comcast
CMCSA
$79.1B
$54.4M 5.69%
1,448,199
+100,713
+7% +$3.74M
BABA icon
2
Alibaba
BABA
$269B
$54.3M 5.67%
503,672
+35,079
+7% +$3.57M
MA icon
3
Mastercard
MA
$477B
$54.2M 5.67%
482,287
+33,954
+8% +$3.72M
GOOG icon
4
Alphabet (Google) Class C
GOOG
$3.9T
$53.5M 5.59%
1,290,860
+89,800
+7% +$3.68M
AGN
5
DELISTED
Allergan plc
AGN
$53.3M 5.57%
223,161
+15,732
+8% +$3.66M
MDT icon
6
Medtronic
MDT
$107B
$49.8M 5.21%
618,574
+132,837
+27% +$10.4M
ALLE icon
7
Allegion
ALLE
$13B
$48.4M 5.05%
638,729
+44,567
+8% +$3.15M
TSM icon
8
TSMC
TSM
$2.09T
$47.1M 4.92%
1,434,356
+259,633
+22% +$8.11M
CME icon
9
CME Group
CME
$92.2B
$39.7M 4.15%
333,975
-24,043
-7% -$2.89M
ANSS
10
DELISTED
Ansys
ANSS
$39.6M 4.14%
370,475
+25,979
+8% +$2.6M
AMGN icon
11
Amgen
AMGN
$203B
$38.2M 3.99%
232,816
+16,945
+8% +$2.82M
DHR icon
12
Danaher
DHR
$135B
$37.4M 3.91%
493,283
+34,734
+8% +$2.59M
COL
13
DELISTED
Rockwell Collins
COL
$35.6M 3.72%
+366,059
New +$34.4M
LBTYA icon
14
Liberty Global Class A
LBTYA
$3.31B
$35M 3.65%
975,122
-104,378
-10% -$3.7M
META icon
15
Meta Platforms (Facebook)
META
$1.51T
$34.8M 3.64%
245,283
+49,724
+25% +$6.64M
SCHW
16
Charles Schwab
SCHW
$177B
$34.7M 3.63%
851,494
-106,768
-11% -$4.41M
HDS
17
DELISTED
HD Supply Holdings, Inc.
HDS
$33.4M 3.48%
810,961
-128,717
-14% -$5.44M
TJX icon
18
TJX Companies
TJX
$170B
$32.6M 3.41%
824,286
+58,094
+8% +$2.24M
DLTR icon
19
Dollar Tree
DLTR
$23.1B
$32M 3.35%
408,213
+28,513
+8% +$2.19M
BIIB icon
20
Biogen
BIIB
$29.9B
$29.3M 3.06%
107,137
+46,592
+77% +$13.2M
ECL icon
21
Ecolab
ECL
$75.6B
$27.1M 2.83%
215,880
+15,214
+8% +$1.86M
WFC icon
22
Wells Fargo
WFC
$261B
$24.6M 2.57%
441,104
+30,740
+7% +$1.74M
FIS icon
23
Fidelity National Information Services
FIS
$21.5B
$23.6M 2.46%
296,019
+20,900
+8% +$1.68M
CHKP icon
24
Check Point Software Technologies
CHKP
$13.3B
$23.3M 2.43%
226,472
-86,001
-28% -$8.43M
SPGI icon
25
S&P Global
SPGI
$126B
$21.3M 2.22%
+162,749
New +$20.2M

Similar funds

Intermede Investment Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Intermede Investment Partners held 29 positions worth $957M, up 12% from $853M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Intermede Investment Partners's Q1 2017 filing shows 2 new, 18 increased, 5 reduced and 4 closed positions. Its largest new stake was Rockwell Collins: 366,059 shares worth $35.6M. The largest sale was B/E Aerospace Inc, an estimated $23.2M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Communication Services and Financials.

  • Intermede Investment Partners's largest Q1 2017 buy was Rockwell Collins: 366,059 shares worth $35.6M.
  • Intermede Investment Partners added most to Biogen in Q1 2017, an estimated $13.2M increase.
  • Intermede Investment Partners's biggest Q1 2017 reduction was Check Point Software Technologies, cutting an estimated $8.43M.
  • Intermede Investment Partners fully exited B/E Aerospace Inc in Q1 2017, selling an estimated $23.2M.
  • Intermede Investment Partners's ten largest holdings make up 52% of its $957M portfolio in Q1 2017.
  • Intermede Investment Partners opened 2 new positions and closed 4 in Q1 2017.
  • Intermede Investment Partners's portfolio value rose 12% quarter-over-quarter to $957M.

Based on Intermede Investment Partners's 13F filing for Q1 2017, filed 25 Apr 2017.